Esther Hong
Stock Analyst at Loop Capital
(n/a)
# 5,090
Out of 5,093 analysts
16
Total ratings
8.33%
Success rate
-41.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Hong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI Atai Beckley | Initiates: Buy | $18 | $4.45 | +304.49% | 2 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $26.76 | -36.47% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $6.30 | +439.68% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $147.56 | -35.62% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $2.31 | -13.42% | 2 | May 20, 2022 | |
| ATHA Athira Pharma | Initiates: Buy | $330 | $3.88 | +8,405.15% | 1 | Apr 21, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $1.04 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $32 | $4.95 | +546.46% | 4 | Dec 16, 2020 |
Atai Beckley
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $4.45
Upside: +304.49%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $26.76
Upside: -36.47%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $6.30
Upside: +439.68%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $147.56
Upside: -35.62%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $2.31
Upside: -13.42%
Athira Pharma
Apr 21, 2022
Initiates: Buy
Price Target: $330
Current: $3.88
Upside: +8,405.15%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $1.04
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: $32
Current: $4.95
Upside: +546.46%